Publication | Closed Access

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial

HepatologyHepatitis CGenotypes 1Viral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyChronic Viral InfectionHepatitis C InfectionAntiviral DrugMedicineTreatment-naive Patients